Who was responsible for the strategy of withholding clinical and preclinical data until it is published in medical journals? DCB and Cullity I assume were a large part of that.
When we received preclinical cardio protection data DT released the news in a way that still allowed the full data to be published at a later date. This strategy allowed the market to know what had been discovered which obviously benefited the share price and shareholders.
Obviously the current strategy to withhold the data hasn’t helped the share price, it’s been smashed due to lack of positive news.
Who benefits from a lower sp and withholding news? Obviously any potential BP buyer.
Maybe a conspiracy theory? Maybe not.
Anyway, Dr T can you please persuade the BOD to revert to the previous strategy and release any data being withheld in the same manner that allows later publication.
We need positive news now and we need lots of it.
Who was responsible for the strategy of withholding clinical and...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.030(2.46%) |
Mkt cap ! $197.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.17 | $25.43K | 21.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 2856 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
-0.030 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.24 | $1.18 | 8334 | ||
| Last updated 15.37pm 06/05/2024 ? | |||||
| RAC (ASX) Chart |